跳到正文

哈门那

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 7 条

  1. 2021

    Humana 就涉嫌 Eylea 定价计划起诉 Regeneron

    提起诉讼

    Humana 起诉 Regeneron,指控 Regeneron 与 Chronic Disease Foundation 涉及一项 Eylea 相关计划,欺诈 Medicare 及其签约支付方。诉状称 Regeneron 抬高 Eylea 价格并向该基金会提供非法回扣;这些是指控,并非已陈述的法院认定。

    来源摘录

    • Humana Inc. filed suit against Regeneron Pharmaceuticals, Inc. Thursday in the Southern District of New York over allegations that the pharmaceutical company engaged in a scheme with the Chronic Disease Foundation. The plaintiff claims that as a result of this purported scheme, which they believe is a “sham charity,” the two parties defrauded Medicare and its contracted payors out of hundreds of millions of dollars.
    • The plaintiff said that Regeneron inflated the price of Eylea and then provided illegal kickbacks to the CDF, which then used the tainted donations they received from Regeneron to cover cost-sharing obligations for patients so that they would continue to choose Eylea rather than its less expensive alternatives.
  2. 2021

    因数据泄露向 Humana 和 Cotiviti 提起集体诉讼

    提起诉讼

    Steven K. Farmer 起诉 Humana 和 Cotiviti,指称两家公司未能妥善保护个人及健康信息,导致数据泄露。该诉讼后来被移送至联邦法院。

    来源摘录

    • The suit was originally filed in May but was removed to federal court Thursday.
    • Steven K. Farmer is bringing suit against Humana, Inc., and Coviti, Inc. over claims that the companies failed to “properly secure and safeguard personal and sensitive information,” which ultimately led to a data breach that compromised Farmer and other class members’ personal identifying information (PII) and personal health information (PHI).
    • The plaintiff asserted that Cotiviti shared both the PII and PHI with a subcontractor who disclosed the information to “unauthorized individuals to promote a personal business endeavor.”
  3. 2019

    仿制药价格操纵诉讼

    Humana提起诉讼,指控数十名被告参与了一项广泛的仿制药价格操纵阴谋。

  4. 2019

    Humana 就仿制药价格起诉制药公司

    提起诉讼

    Humana 提起诉讼,指控 37 家制药公司参与行业范围的合谋,导致多种仿制药价格上涨;这是原告的主张,并非法院认定。

    来源摘录

    • Louisville-based Humana Inc. has filed a 600-plus page lawsuit alleging 37 pharmaceutical companies — several of which are international powerhouses — engaged in an industrywide conspiracy that sent the cost of several generic drugs skyrocketing.
    • Filed on Friday, the lawsuit from the Louisville-based health insurer and health services provider claims the so-called conspiracy resulted in some generic drug prices increasing by over 1,000 percent.
  5. 2009

    对Medicare邮件调查

    美国卫生与公众服务部调查了Humana向Medicare受益人发送的邮件,批评者称这些邮件可能被误认为是官方政府信息,并包含有关医疗改革的声明。监管机构指示公司在审查期间暂停发送邮件。

  6. 1999

    关于移植治疗覆盖范围的争议

    Michael Moore制作的电视节目批评Humana拒绝为需要移植的糖尿病患者提供治疗。在公众行动之后,Humana改变了政策并授权治疗,但后来对事件的某些方面提出异议。

  7. 1996

    关于管理式护理激励的国会证词

    曾作为Humana承包商的医生Linda Peeno在国会就管理式护理激励作证,并声称一项覆盖决定获得了经济奖励。Humana后来对她的描述和就业状况提出异议。